Product description

The food supplement for the management of persistent HPV infections. One clinical trial demonstrated a clearance of HPV in 85% of patients after 3 months of administration. One case report and one in-vitro study further support safety and efficacy, while there are two ongoing clinical trials.
Read more

Specifications

Categories Specialised Finished ProductsDietary supplements
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Italy
Certifications Quality assurance

More products from LO.LI. PHARMA INTERNATIONAL S.R.L.

Products from other suppliers